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Abstract: Myocardial deformation imaging (strain imaging) is a technique to directly quantify
the extent of myocardial contractility and overcomes several of the limitations of ejection
fraction. The application of the most commonly used strain imaging method; speckle-tracking
echocardiography to patients with sepsis cardiomyopathy heralds an exciting development to the
field. However; the body of evidence and knowledge on the utility, feasibility and prognostic value
of left ventricular global longitudinal strain in sepsis cardiomyopathy is still evolving. We conducted
a review of literature on utility of left ventricular global longitudinal strain in sepsis cardiomyopathy.
We discuss the role of left ventricular global longitudinal strain in mortality prediction, utility and
limitations of the technique in the context of sepsis cardiomyopathy.
Keywords: sepsis cardiomyopathy; left ventricular function; global longitudinal strain
1. Introduction
Left ventricular (LV) function is a powerful predictor of prognosis in a number of conditions
and has been shown specifically to be predictive of outcomes in sepsis [1]. Sepsis cardiomyopathy,
the reversible myocardial depression that occurs early in severe sepsis and septic shock was first
described in 1970s [2]. Utilizing radionuclide angiography, Parker et al. [2] reported that 50% of
patients with septic shock had severely reduced baseline LV ejection fraction which was paradoxically
lower in survivors. An accepted definition of sepsis cardiomyopathy is based on an LV ejection fraction
of less than 45% to 50% in the absence of previously diagnosed cardiac disease that demonstrates
reversibility upon remission in patients without prior cardiomyopathy [3]. This definition was evolved
prior to the availability of echocardiographic techniques such as speckle tracking echocardiography [4].
The traditional method used to assess LV function (in the ICU) has been determination of LV
ejection fraction, usually based on visual analysis of two-dimensional (2D) images or Simpson biplane
method [5]. This long relied-upon parameter to describe LV systolic function is relatively easy to
acquire and is a concept familiar to most clinicians. However, significant limitations of using LV
ejection fraction to characterize systolic function are recognized. The use of 2D echocardiography to
describe cardiac function is influenced by geometric assumptions, and technical issues, such as apical
foreshortening and difficulties in proper delineation of the endocardial borders, limit its accuracy.
As a parameter to assess LV function, ejection fraction is highly dependent on loading conditions
and as such does not directly reflect the underlying lying state of LV myocardial contractility. In
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addition, the reproducibility of this method is quite high with significant inter-observer variability
reported [6–8].
Given these limitations, a method that more directly assesses intrinsic myocardial contractility
would be desired for clinical use. Myocardial deformation imaging (also known as strain imaging)
provides a means to directly quantify the extent of myocardial contractility and overcome several
of the limitations of using ejection fraction for this purpose. Strain, a unit-less parameter, is defined
as the percentage change in the length (deformation) of a myocardial segment over a given period
of time compared to the resting state. The most widely used method to perform strain imaging is
speckle-tracking echocardiography, a technique which makes use of the presence of unique acoustic
markers (“speckles”) within the myocardium to track their position throughout the cardiac cycle.
This method offers distinct advantages in comparison to earlier (and now rarely-used) Doppler-based
techniques [9] and is now available on most current generation echocardiography platforms. Strain can
be assessed in 3 principle directions (longitudinal, circumferential, and radial), however longitudinal
strain is the most reproducible. Furthermore, as global strain has much better reproducibility than
segmental strains, it is currently recommended that global longitudinal strain (GLS) be the parameter
used to describe LV systolic function [5]. In an effort to provide some guidance, the most recent
recommendation from the American Society of Echocardiography (ASE) and the European Association
of Cardiovascular Imaging (EACVI) states that a peak GLS in the range −20% can be expected in a
healthy person.
Strain-imaging by speckle-tracking echocardiography has been shown to have clinical utility
in a variety of settings [9] and to offer superior prognostic value to ejection fraction for predicting
major adverse cardiac events [10]. Advantages of using GLS to assess LV systolic function compared
to ejection fraction include better reproducibility, ability to identify sub-clinical LV dysfunction,
non-reliance on geometric assumptions, and lack of influence by tethering effects.
As the utility of GLS measurement by speckle tracing echocardiography has shown accuracy
in predicting outcomes in several pathological conditions, it is logical to examine the role of GLS by
speckle tracking 2D echocardiography in ICU patients with sepsis and sepsis cardiomyopathy.
Since GLS is most reproducible and commonly used strain parameter, we sought to review the
current literature on role of GLS in sepsis cardiomyopathy with a focus on current limitations, pitfalls
of strain acquisition, standardization and clinical relevance towards mortality prediction.
2. Materials and Methods
We conducted a review of current literature on the utility and prognostic value of left ventricular
global longitudinal strain in patients with sepsis cardiomyopathy.
We have conducted a systematic search of PubMed data search for (((((sepsis OR septic)) AND
(cardiac output OR echo OR TTE)) AND (heart diseases/etiology OR heart assist devices OR heart
failure OR dysfunction OR ejection factor)) AND (strain) OR (speckle)) from January 1976 to December
2017. Our search strategy focused on Left Ventricle GLS and adult literature.
Inclusion criteria were human randomized trials, prospective or retrospective observational
cohort studies which reported mortality in patients with sepsis, severe sepsis, and/or septic shock
utilizing speckle tracking GLS. We have excluded case reports, case series, case-control studies, studies
that utilized non-speckle tracking echocardiography methods and studies for which a 2 × 2 table
between GLS and mortality could not be constructed by usage of published data. The final results
did not include gray or intermediary material. The final study inclusions were based on consensus of
2 reviewers. The third independent reviewer (D.T.) served as the expert referee in case of disagreement.
Details of search strategy were included in supplement Tables S1–S3.
The heterogeneity of data in terms of GLS acquisition platforms, proprietary algorithms used for
GLS interpretation and patient heterogeneity precludes the combination of data utilizing meta-analysis
methods. Hence, we conducted a review of literature.
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Out of the initial 191 human studies identified on screening, 8 studies were deemed suitable for
analysis and relevant clinical, echocardiographic and outcome, mortality data was tabulated.
3. Results
To further assess the role of GLS in sepsis and sepsis-related cardiomyopathy, we tabulated
available relevant GLS studies in sepsis cardiomyopathy by performing a literature search for GLS
and/or sepsis and/or cardiomyopathy and highlight the following: (Tables 1–3).
We tabulated 8 studies including 846 subjects with severe sepsis and/or septic shock. With the
exception of 1 study [11] which utilized the Sepsis 3 definition [12]; all others were based on Sepsis
2 criteria [13]. Significant heterogeneity in subjects exists: 5 studies included septic shock patients,
2 studies [14,15] included patients with both severe sepsis and/or septic shock (Table 1).
Of the 846 patients included in these studies, 297 (35.1%) were eliminated from further analysis by
various exclusion criteria (Table 2) illustrating the difficulties in quality image acquisition in a timely
manner in this set of severely ill patients. With a single exception [14], all studies involved only a
single center site.
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Table 1. Description of studies including design, inclusion criteria, subjects and imaging platforms/software.
Study Setting Geography StudyDesign Study Period
Total
Patients
Excluded
Pts
No. of
Centers
Inclusion
Criteria
Primary
Outcome
Secondary
Outcomes
Cut off
Threshold
GLS
Echo
Machine Software Timing Operator r
2 Intra r2 Inter Ventilator Shock
(%) (%) (%)
Chang et al.,
2015 [16]
University
Hospital ICU Taiwan
Prospective
observational
January
2011–June
2013
111 25 1 Septic shock ICUmortality
Hospital
mortality −13
GE
Vivid-I
or Q
EchoPAC <24 h 2 blinded 0.88 0.94
De Geer et al.,
2015 [17]
University
Hospital
mixed ICU
Sweden Prospectiveobservational
October
2012–September
2014
44 7 1 Septic shock ICUmortality
30 days, 90
days
mortality
−15 GE VividE9
EchoPAC
112 <24 h 1 0.92 84
Landesberg et
al., 2014 [18]
Tertiary
academic
institute
Israel Prospectiveobservational
April
2009–March
2011
106 14 1
Severe sepsis
and septic
shock
hs-cardiac
troponin
elevation
Hospital
mortality
Philips
IE33
Philips
Qlab 8.1 <24 h 2 blinded 100
Orde et al., 2014
[19]
Tertiary
academic
center
USA Prospectiveobservational
August
2007–January
2009
60 13 1
Severe sepsis
and septic
shock
30 days
mortality
6 months
mortality −17
GE Vivid
7
Syngo
Velocity
Vector
<24 h 3 0.9 ± 0.9 0.8 ± 0.5 65
Palmeieri et al.,
2015 [20]
ED-HDU
academic
center
Italy Prospectiveobservational
October
2012–April
2015
115 34 1 Sepsis andseptic shock
28 days
mortality
7 days
mortality
Philips
IE33
Philips
Qlab 8.1 <24 h 3 blinded 0.9 0.82 0 39
Zaky et al., 2016
[15]
Tertiary care
center any ICU USA
Retrospective
observational
January
2008–December
2011
54 43 1
Sepsis
and/or
septic shock
In-hospital
mortality
Mechanical
ventilation,
ICU &
hospital stay
−15 PhilipsIE33
Philips
Qlab 4.1 <7 days 5 0.83 0.84
Lanspa et al.,
2017 [14]
Tertiary
academic
centers (2
hospitals, 3
ICUs)
USA Prospectiveobservational
October
2012–November
2015
298 154 2
Severe sepsis
or septic
shock
In-hospital
mortality,
28 days
mortality
Organ
failure free
days
−17
Philips
IE33 or
CX50
Image
Arena <24 h 31 39
Yang et al., 2017
[11]
Academic
center China
prospective
observational
January
2016–April
2017
58 7 1 Septic shockper sepsis 3
28 days
mortality
GE
Vivid-Q EchoPAC
<24 h,
day
1,3,7,14
2 100
These published studies utilized different strain analysis software and echo imaging platforms (Table 1): Philips Qlab 8.1® was utilized in 3 studies (n = 352), EchoPACS® in 3 studies
(n = 213), Image Arena® in 1 study (n = 298) and Syngo Velocity Vector® (n = 60). Philips IE 33® was used for Image acquisition in 4 studies (n = 573) and GE Vivid® in 4 studies (n = 273).
The end points reported were heterogeneous and variable (Table 3).
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Table 2. Exclusion Criteria.
Study Exclusion Criteria
Chang et al., 2015 [16] none
De Geer et al., 2015 [17] death < 24 h, treatment limitations, no consent, Heart Failure, Ischemic Heart Disease
Landesberg et al., 2014 [18] Moderate mitral/aortic disease, poor windows, Atrial Fibrillation, arrhythmia, Regional Wall Motion Anamoly
Orde et al., 2014 [19] pregnancy, congenital Heart Disease, poor image quality, prosthetic valves, cardiomyopathy, moderate or severevalve disease
Palmeieri et al., 2015 [20] poor windows, greater than moderate aortic or mitral valve disease
Zaky et al., 2016 [15] Age < 18 years, Atrial Fibrillation, LVEF < 40%, valve disease, valve replacement, ICDs, poor Echo views
Lanspa et al., 2017 [14] echo > 24 h, poor image quality
Yang et al. 2017 [11] Myocardial Infraction, congenital, valvular heart disease, hospitalization < 24 h, malignancy, liver, kidney failure,pericardial effusion, advanced malignancy, poor image quality
These published studies utilized different strain analysis software and echo imaging platforms (Table 1): Philips Qlab 8.1® was utilized in 3 studies (n = 352), EchoPACS® in 3 studies
(n = 213), Image Arena® in 1 study (n = 298) and Syngo Velocity Vector® (n = 60). Philips IE 33® was used for Image acquisition in 4 studies (n = 573) and GE Vivid® in 4 studies (n = 273).
The end points reported were heterogeneous and variable (Table 3).
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Table 3. Outcomes.
Study
ICU Non
Survivor
GLS
ICU
Survivor
GLS
Hospital
Non
Survivor
GLS
Hospital
Survivor
GLS
28 Days
Non
Survivor
GLS
28 Days
Survivor
GLS
30 Days
Non
Survivor
GLS
30 Days
Survivor
GLS
90 Days
Non
Survivor
GLS
90 Days
Survivor
GLS
6 Months
Non
Survivor
GLS
6 Months
Survivor
GLS
Abnormal
GLS
Hospital
Mortality
Abnormal
GLS
Hospital
Mortality
Normal
GLS
Hospital
Mortality
Abnormal
GLS 28
Days
Mortality
Mean± SD
in % Alive n (%) Dead n (%) Dead n (%) Dead n (%)
Chang et al.,
2015 [16] −11.8 ± 4.5 −15 ± 3.6 −12.4 ± 4.9 −14.9 ± 3.4
De Geer et al.,
2015 [17]
−15 (−19.7
to −11)
−17.2 (−20
to −13)
−14.7 (−19
to −10.6)
−17.4
(−20.5 to
−13.6)
Landesberg et
al., 2014 [18] −12.3 ± 3.6 −13.7 ± 2.7
Orde et al.,
2014 [19] −14.6 ± 4.3 −13.92 ± 4.2 −14.28 ± 4.6 −14 ± 4
Palmeieri et
al., 2015 [20] −9.1 ± 3.6 −10.8 ± 3.2
Zaky et al.,
2016 [15] 24 (80) 12 (66.7)
Lanspa et al.,
2017 [14] 47 (22) 31 (17) 54 (25)
Yang et al.,
2017 [11]
−15.98 ±
1.41
−17.66 ±
1.22
These published studies utilized different strain analysis software and echo imaging platforms (Table 1): Philips Qlab 8.1® was utilized in 3 studies (n = 352), EchoPACS® in 3 studies
(n = 213), Image Arena® in 1 study (n = 298) and Syngo Velocity Vector® (n = 60). Philips IE 33® was used for Image acquisition in 4 studies (n = 573) and GE Vivid® in 4 studies (n = 273).
The end points reported were heterogeneous and variable (Table 3).
Healthcare 2019, 7, 5 7 of 9
4. Discussion
Several recent studies and a review/meta-analysis [21] shed light on the important question;
is GLS is a better predictor of mortality in sepsis cardiomyopathy than the traditional parameter;
LV ejection fraction. In their meta-analysis [21], the authors pooled available and eligible observational
studies that included 794 patients with severe sepsis and/or septic shock. The pooled data, stratified
by survivors/non-survivor, showed that GLS measurements were strongly associated with survival
(standard mean difference (SMD) −0.26; 95% confidence interval (CI) −0.47, −0.04; p = 0.02) while in
contrast, LV ejection fraction was found not to be a predictor of mortality.
Before conclusions can be drawn about GLS’s utility and prognostic value, caution should be
applied in interpreting the results of the meta-analysis [21] in view of the heterogeneity, observational
nature of the component studies, especially differences in image acquisition platforms and inter-vendor
variability in speckle tracking algorithms.
Another recent systematic review [22] which analyzed total of 455 patients [23] did not combine
the data by usage of meta-analysis methods citing significant methodological and statistical differences
between the studies which concurs with our concerns. The current review included studies published
in later half of 2017 and not restricted to studies published in English. We highlight the current
inherent limitations of GLS; arising from proprietary differences in image acquisition platforms and
inter-vendor variability in speckle tracking algorithms.
At present no accepted GLS thresholds that define sepsis cardiomyopathy exist. The traditionally
used abnormal threshold of −20% to define Left ventricular dysfunction may not apply to the
setting of sepsis cardio myopathy in the critically ill population [24] and ASE-chamber quantification
guideline [5]. The common observation in current literature in terms of predicting outcome is that the
lower (less negative) the value for GLS, the worse the outcome, especially among patients “normal”
LV ejection fractions.
Practical difficulties in obtaining reliable and timely bedside measurements of GLS exist.
Issues with standardization [24], Inter-Vendor differences [25,26], incorporation/availability
of required software in point of care ultrasound machines, training of bedside ICU providers on
measurements of GLS, the limited echo windows which may be available in ICU subjects and
time constraints to measure GLS (currently off-line for the most part) in the critically ill subset
of patients should be recognized and need to be overcome to make this assessment more robust.
The current review is not an exhaustive, comprehensive literature search and intends to serve
the purpose of outlining the current body of knowledge and limitations of GLS in the context of
sepsis cardiomyopathy.
5. Conclusions
As the literature on this topic continues to evolve and data accumulates on the value of GLS
in sepsis and sepsis cardiomyopathy, the time has arrived to conduct prospective, multi-center
investigations to define the role of GLS and potential prognostication thresholds in the management
of these critically-ill patients. As such studies are designed, investigators need to take into account
the limitations of the prior studies as listed above. Efforts towards future standardization of GLS
measurements as being proposed by European Association of Cardiovascular Imaging (EACVI)
American Society of Echocardiography (ASE) strain standardization task force will potentially apply
to future studies and bring the much needed standardization, facilitation of data pooling and wider
applicability of GLS to critical care patients. Future studies should be done utilizing Sepsis 3
definition [16], GLS measurements at pre-defined time points during resuscitation and exploring
a combination of patient centric outcome measures (such as duration of mechanical ventilation,
duration of pressors, ICU stay, volume status) in addition to mortality outcomes. Until such studies
are performed, GLS remains just another tool in our toolbox in the assessment of these complex,
critically-ill patients.
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In summary, the parameter of GLS heralds an exciting but evolving new era and appears to
represent a significant advance in the field of sepsis cardiomyopathy.
Supplementary Materials: The following are available online at http://www.mdpi.com/2227-9032/7/1/5/s1,
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